Some once common treatment, such as anti-tumor necrosis factor (TNF)-α antibodies5, 6, interleukin (IL)-1 receptor antagonists7, and platelet-activating factor (PAF) antagonists8, 9, etc., fails to improve the cure and survival rates of sepsis. This evidence concerns the gene TNF and Sepsis.